Moreover, SMYD3 serum levels in HCC patients with the SMYD3 VNTR genotype 3/3 were higher than in those with genotypes 2/2 and 2/3; this difference was not observed in CHB and LC patients. The gene discussed is SMYD3; the disease is hepatocellular carcinoma.